Life Sciences

The biopharma sector in the US is a critical industry dedicated to the research, development, and production of pharmaceuticals and biotechnology products for healthcare solutions. Decision-makers in this sector encounter a range of challenges, including the high cost and time associated with drug development and regulatory approval, as well as the need to maintain innovation while ensuring patient safety and addressing complex ethical and legal considerations. Our publications that cover biopharma report on topics such as clinical readouts to FDA approvals, gene therapy to drug pricing and M&A to research partnerships.

The healthcare sector in the US is a vast and complex industry, encompassing a wide range of healthcare providers, insurance companies, and medical technologies. Decision-makers in this sector grapple with a multitude of challenges, including the need to address rising healthcare costs, improve accessibility and quality of care, and manage the intricate web of regulatory requirements. Our publications that cover healthcare report on topics such as health IT, policy & regulation, insurance, digital health, payer-provider partnerships, value-based care and more.

The medical device sector in the US is a critical industry encompassing the design, manufacturing, and distribution of a wide range of healthcare equipment and technology, from surgical instruments to diagnostic devices. Decision-makers in this sector face numerous challenges, including navigating complex regulatory pathways, ensuring product safety and efficacy, and staying up-to-date with rapidly evolving medical technologies. Our publications that cover medtech report on topics such as medical devices, diagnostics, digital health, regulation/compliance, R&D, M&A and more.